BPC-157, a synthetic 15-amino acid peptide sometimes used to treat ulcerative colitis, and KPV, which is used for inflammatory conditions, were the first peptides considered on July 23 for addition to the 503A bulks list
The researchers of a study investigating the potential of the peptide on these factors propose this as a possible mechanism of action for TB-500
Phase 2b completed in T2D) Status: Investigational not approved by FDA or EMA Heres what makes it different from everything else on the market and in the pipeline: - Semaglutide (Ozempic/Wegovy/Rybelsus): GLP-1 only - Tirzepatide (Mounjaro/Zepbound): GLP-1 + GIP - Retatrutide (investigational): GLP-1 + GIP + Glucagon - Amycretin : GLP-1 + Amylin Different receptor pairing
AUC 090min , area under the concentration/time curve at last observation
As much of the B12 in our diet comes from animal products, vegans are at higher risk of getting a B12 deficiency
Some athletes swear by it for quicker injury recovery, bio-hackers are experimenting with it to optimize health, and those dealing with chronic pain are hopeful it could offer some relief
